Constitutive expression of the DNA-binding domain of Ets1 increases endothelial cell adhesion and stimulates their organization into capillary-like structures.
We previously reported that the Ets1 transcription factor is expressed in endothelial cells during angiogenesis both in normal and pathological development. We analyse here the effects of the stable expression of an Ets transdominant negative mutant (Ets1-DB), consisting in an Ets1 protein lacking its transactivation domain. A retrovirus containing the Ets1-DB sequence fused to an IRES-Neo sequence was designed and used to infect brain capillary (IBE) and aorta (MAE) mouse endothelial cell lines. Cells expressing this Ets1 mutant were examined for proliferation, migration and adhesion. Consistent changes were observed on cell morphology, with increased spreading and modifications in the organization of the cytoskeleton, and increased cell adhesion. We investigated the ability of endothelial cells to organise into capillary-like structures using three-dimensional gels. On Matrigel, all endothelial cell lines formed a cord-like network within 24 h, with an increased ability of Ets1-DB cells to spread on this substrate. In long term cultures, IBE cells expressing Ets1-DB showed a higher capacity to form branched structures; this effect was potentiated by FGF2. These results demonstrate a role of the Ets transcription factors in the regulation of the adhesive and morphogenetic properties of endothelial cells.
Mattot
V
V
CNRS EP560-Institut Pasteur de Lille, Institut de Biologie de Lille, France.
Vercamer
C
C
Soncin
F
F
Calmels
T
T
Huguet
C
C
Fafeur
V
V
Vandenbunder
B
B
D016475:3T3 Cells; D000818:Animals; D001011:Aorta; D001921:Brain / Q000098:blood supply; D002196:Capillaries / Q000166:cytology*; D002448:Cell Adhesion / Q000235:genetics*; D002455:Cell Division; D002465:Cell Movement; D002478:Cells, Cultured; D003094:Collagen; D003599:Cytoskeleton / Q000648:ultrastructure; D018076:DNA, Complementary / Q000235:genetics; D004338:Drug Combinations; D004730:Endothelium, Vascular / Q000166:cytology* / Q000378:metabolism; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D007365:Intercellular Junctions / Q000648:ultrastructure; D007797:Laminin; D051379:Mice; D009024:Morphogenesis / Q000235:genetics; D018919:Neovascularization, Physiologic / Q000235:genetics*; D009928:Organ Specificity; D011509:Proteoglycans; D050784:Proto-Oncogene Protein c-ets-1; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D050783:Proto-Oncogene Proteins c-ets; D011993:Recombinant Fusion Proteins / Q000502:physiology; D014157:Transcription Factors / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*
D018076:DNA, Complementary; D004338:Drug Combinations; C494042:Ets1 protein, mouse; D007797:Laminin; D011509:Proteoglycans; D050784:Proto-Oncogene Protein c-ets-1; D011518:Proto-Oncogene Proteins; D050783:Proto-Oncogene Proteins c-ets; D011993:Recombinant Fusion Proteins; D014157:Transcription Factors; D016222:Fibroblast Growth Factor 2; C059485:matrigel; D003094:Collagen